Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.62 |
| ▸ | KLK7 | P49862 | 2/20 | 0.60 |
| ▸ | KLK5 | Q9Y337 | 2/20 | 0.60 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.54 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.53 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.53 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.53 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30340359 | 0.92 | MAPT (0.60) | MAPTKLK7KLK5ITGB3ITGA2B | |
| SCHEMBL17309872 | 0.92 | MAPT (0.68) | MAPTKLK7KLK5ABCB1ITGB3 | |
| SCHEMBL1303931 | 0.92 | MAPT (0.68) | MAPTKLK7KLK5ABCB1ITGB3 | |
| SCHEMBL13599694 | 0.91 | MAPT (0.56) | MAPTKLK7KLK5FOLH1PAX8 | |
| SCHEMBL30668140 | 0.89 | KLK7 (0.57) | MAPTKLK7KLK5ITGB3ITGA2B | |
| SCHEMBL29460426 | 0.89 | KLK7 (0.61) | MAPTKLK7KLK5ABCB1ITGB3 | |
| SCHEMBL10035709 | 0.89 | SYK (0.54) | MAPTKLK7KLK5ITGB3ITGA2B | |
| SCHEMBL8955505 | 0.89 | KLK7 (0.64) | MAPTKLK7KLK5ABCB1ITGB3 | |
| SCHEMBL30064541 | 0.88 | MAPT (0.62) | MAPTKLK7KLK5ABCB1ITGB3 | |
| SCHEMBL26016962 | 0.88 | MAPT (0.54) | MAPTKLK7KLK5FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4538279-A2 | REACTION AGENT FOR AMIDE REACTIONS AND AMIDE COMPOUND PRODUCTION METHOD USING SAME | Chubu University Educational Foundation (JP) | 2025-04-16 | — | — | EP | disclosed |
| US-20230121469-A1 | CATALYST FOR MANUFACTURING AMIDE COMPOUND, AND METHOD FOR MANUFACTURING AMIDE COMPOUND | CHUBU UNIVERSITY EDUCATIONAL FOUNDATION (JP) | 2023-04-20 | — | — | US | disclosed |
| US-20230002422-A1 | REACTION AGENT FOR AMIDE REACTIONS AND AMIDE COMPOUND PRODUCTION METHOD USING SAME | CHUBU UNIVERSITY EDUCATIONAL FOUNDATION (JP) | 2023-01-05 | — | — | US | disclosed |
| EP-4053132-A1 | REACTION AGENT FOR AMIDE REACTIONS AND AMIDE COMPOUND PRODUCTION METHOD USING SAME | Chubu University Educational Foundation (JP) | 2022-09-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230002422-A1 | REACTION AGENT FOR AMIDE REACTIONS AND AMIDE COMPOUND PRODUCTION METHOD USING SAME | NAAA, NOTUM, ASNS | MAPT 4225/4885KLK7 3281/4885KLK5 2966/4885 |
| US-20230121469-A1 | CATALYST FOR MANUFACTURING AMIDE COMPOUND, AND METHOD FOR MANUFACTURING AMIDE COMPOUND | NAAA, ASNS, BCAT2 | MAPT 3585/4885KLK7 1452/4885KLK5 1305/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.